title: Should We Add Pravastatin to Aspirin for Preeclampsia Prevention in High-risk Women?
abstract: Preeclampsia is a multisystem disorder that affects 3% to 5% of pregnant women and remains a significant source of short-term and long-term maternal and neonatal mortality and morbidity. Many professional societies recommend the use of low-dose aspirin to prevent preeclampsia in high-risk women. Owing to the similarities in pathophysiology between preeclampsia and atherosclerotic cardiovascular disease, and the encouraging data from preclinical and pilot clinical studies, pravastatin has been proposed for preventing preeclampsia. However, before statin administration becomes part of routine clinical practice, a large, well-designed, and adequately powered randomized-controlled trial is needed.
authors.affiliation: Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, The University of Texas Medical Branch, Galveston, Texas.
authors.forename: Caroline C
authors.initials: CC
authors.lastname: Marrs
authors.forename: Maged M
authors.initials: MM
authors.lastname: Costantine
mesh_terms: D001241:Aspirin / Q000008:administration & dosage*; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D017035:Pravastatin / Q000008:administration & dosage*; D011225:Pre-Eclampsia / Q000517:prevention & control*; D011247:Pregnancy; D012307:Risk Factors
chemical_list: D005343:Fibrinolytic Agents; D017035:Pravastatin; D001241:Aspirin